A detailed history of Scientech Research LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Scientech Research LLC holds 20,151 shares of HALO stock, worth $987,399. This represents 0.23% of its overall portfolio holdings.

Number of Shares
20,151
Previous 19,839 1.57%
Holding current value
$987,399
Previous $1.04 Billion 11.04%
% of portfolio
0.23%
Previous 0.21%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$51.3 - $64.42 $16,005 - $20,099
312 Added 1.57%
20,151 $1.15 Billion
Q2 2024

Aug 14, 2024

BUY
$37.81 - $52.4 $439,541 - $609,150
11,625 Added 141.53%
19,839 $1.04 Billion
Q1 2024

May 15, 2024

BUY
$33.68 - $41.95 $276,647 - $344,577
8,214 New
8,214 $334 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.83B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Scientech Research LLC Portfolio

Follow Scientech Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scientech Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scientech Research LLC with notifications on news.